Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 837.40
-17.40 (-2.04%)
Apr 28, 2026, 5:24 PM IDT
Epitomee Medical Company Description
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel.
The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions.
Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Epitomee Medical Ltd
| Country | Israel |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Radan Hashimshony |
Contact Details
Address: 17 Hatochon St Caesarea, 3079892 Israel | |
| Phone | 972 7 4740 0799 |
| Website | epitomeemedical.com |
Stock Details
| Ticker Symbol | EPIT |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011825911 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Argil Cohen | Chief Executive Officer of Research & Development |
| Dr. Radan Hashimshony Ph.D. | Chief Executive Officer and General Secretary |
| Dr. Shimon Eckhouse Ph.D. | Co-Founder and Chairman of the Board |
| Gal Aharonowitz | Chief Operating Officer |
| Dr. Yael Kidan | Vice President of Clinical Affairs |
| Maya Gabrieli | Chief Financial Officer |
| Alon Heth | Vice President of Sales and Marketing |